Clinical trial
Phase II Trial of Molecularly Determined Treatment of Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
NCT01182350 is registered in ClinicalTrials.gov with Karen D. Wright MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of Molecularly Determined Treatment of Children and Young Adults With Newly Diagnosed Diffuse Intrinsic Pontine Gliomas
- Lead sponsor
- Karen D. Wright MD
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 30, 2011
- Completion date
- June 30, 2016
- Enrollment
- 53 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.